CHINA GEWANG BIOTECHNOLOGY, INC. Financial Statements (2026 and earlier)
Company Profile
| Business Address |
XITA 23C STAR INTERNATIONAL, 8 JINSUI GUANGZHOU PROVINCE, 510623 |
| State of Incorp. | NV |
| Fiscal Year End | November 30 |
| Industry (SIC) | 20 - Food And Kindred Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 5/31/2017 Q2 | 2/28/2017 Q1 | 11/30/2016 Q4 | 8/31/2016 Q3 | 5/31/2016 Q2 | 2/29/2016 Q1 | 11/30/2015 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 16,983 | 13,108 | 9,785 | 16,691 | 14,181 | 8,669 | |||
| Cash and cash equivalent | 16,983 | 13,108 | 9,785 | 16,691 | 14,181 | 8,669 | |||
| Receivables | 14,374 | 14,848 | 14,848 | ||||||
| Inventory, net of allowances, customer advances and progress billings | 106 | 108 | 122 | 22 | 40 | 157 | |||
| Inventory | 106 | 108 | 122 | 22 | 40 | 157 | |||
| Prepaid expense | 3,564 | 5,540 | 30 | 76 | 8 | ||||
| Other undisclosed current assets | 11,205 | 3,393 | (9,702) | 488 | 461 | ||||
| Total current assets: | 35,027 | 29,961 | 28,179 | 21,859 | 14,785 | 9,295 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 116 | 129 | 117 | 117 | 133 | 66 | |||
| Long-term investments and receivables | 8,156 | 6,003 | 3,610 | 1,875 | |||||
| Long-term investments | 8,156 | 6,003 | 3,610 | 1,875 | |||||
| Intangible assets, net (including goodwill) | 66 | ||||||||
| Intangible assets, net (excluding goodwill) | 66 | ||||||||
| Deferred costs | 165 | 110 | |||||||
| Other undisclosed noncurrent assets | 22,116 | 18,856 | 14,488 | 8,846 | |||||
| Total noncurrent assets: | 8,438 | 6,242 | 25,843 | 20,848 | 14,621 | 8,977 | |||
| Other undisclosed assets | (22,116) | (18,856) | (14,488) | (8,912) | |||||
| TOTAL ASSETS: | 43,465 | 36,203 | 31,906 | 23,852 | 14,917 | 9,361 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 5,483 | 4,157 | 33 | 20 | 33 | 33 | |||
| Taxes payable | 1,135 | 789 | |||||||
| Accounts payable | 4,349 | 3,367 | |||||||
| Accrued liabilities | 33 | 20 | 33 | 33 | |||||
| Debt | 228 | 228 | |||||||
| Due to related parties | 367 | 238 | |||||||
| Other undisclosed current liabilities | 190 | 193 | 5,871 | 2,881 | 291 | 372 | |||
| Total current liabilities: | 6,269 | 4,816 | 5,904 | 2,902 | 324 | 405 | |||
| Noncurrent Liabilities | |||||||||
| Other undisclosed noncurrent liabilities | 211 | 230 | 211 | 190 | |||||
| Total noncurrent liabilities: | 211 | 230 | 211 | 190 | |||||
| Other undisclosed liabilities | 13,054 | 10,043 | 4,609 | ||||||
| Total liabilities: | 6,269 | 4,816 | 6,115 | 16,186 | 10,577 | 5,205 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 36,867 | 31,133 | 26,002 | 20,950 | 14,593 | 8,590 | |||
| Common stock | 75 | 75 | 75 | 75 | 58 | 46 | |||
| Additional paid in capital | 16,980 | 16,980 | 16,980 | 16,811 | 11,987 | 6,526 | |||
| Accumulated other comprehensive loss | (1,655) | (1,707) | (429) | (252) | |||||
| Retained earnings | 20,708 | 15,026 | 8,906 | 4,016 | 2,566 | 2,270 | |||
| Other undisclosed equity, attributable to parent | 759 | 759 | 41 | 48 | 412 | ||||
| Equity, attributable to noncontrolling interest | 329 | 255 | |||||||
| Other undisclosed equity | (13,284) | (10,253) | 282 | ||||||
| Total equity: | 37,196 | 31,388 | 26,002 | 7,666 | 4,340 | 8,871 | |||
| Other undisclosed liabilities and equity | (211) | (4,715) | |||||||
| TOTAL LIABILITIES AND EQUITY: | 43,465 | 36,203 | 31,906 | 23,852 | 14,917 | 9,361 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 5/31/2017 Q2 | 2/28/2017 Q1 | 11/30/2016 Q4 | 8/31/2016 Q3 | 5/31/2016 Q2 | 2/29/2016 Q1 | 11/30/2015 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 21,142 | 20,276 | 18,588 | 5,437 | 1,218 | 1,111 | ||
| Revenue, net | 19,014 | |||||||
| Cost of revenue | (13,914) | (28,766) | ||||||
| Cost of product and service sold | (13,914) | |||||||
| Other undisclosed gross profit | 14,519 | (11,151) | (3,025) | (343) | (289) | |||
| Gross profit: | 7,228 | 6,029 | 7,437 | 2,412 | 875 | 822 | ||
| Operating expenses | (2,406) | (925) | (2,551) | (772) | (408) | (515) | ||
| Operating income: | 4,822 | 5,105 | 4,887 | 1,640 | 468 | 307 | ||
| Nonoperating income (expense) | (1) | 1,745 | 292 | 193 | 8 | |||
| Investment income, nonoperating | 1,741 | 415 | 5 | 5 | ||||
| Gain (loss), foreign currency transaction, before tax | (122) | 186 | 3 | |||||
| Other nonoperating income (expense) | (1) | 5 | 1 | |||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (1,219) | (2,151) | ||||||
| Income from continuing operations before equity method investments, income taxes: | 3,602 | 2,953 | 6,632 | 1,932 | 661 | 315 | ||
| Income from equity method investments | 2,153 | |||||||
| Other undisclosed income (loss) from continuing operations before income taxes | (934) | 4,537 | ||||||
| Income from continuing operations before income taxes: | 4,821 | 7,490 | 6,632 | 1,932 | 661 | 315 | ||
| Income tax expense | (1,219) | (1,305) | (1,231) | (417) | (123) | (120) | ||
| Other undisclosed loss from continuing operations | (3,675) | (13,901) | ||||||
| Income (loss) from continuing operations: | (73) | (7,716) | 5,401 | 1,516 | 537 | 196 | ||
| Income (loss) before gain (loss) on sale of properties: | (73) | (7,716) | 5,401 | 1,516 | 537 | 196 | ||
| Other undisclosed net income (loss) | 5,828 | 13,911 | (10) | 122 | (186) | (89) | ||
| Net income: | 5,755 | 6,195 | 5,391 | 1,638 | 351 | 107 | ||
| Net income attributable to noncontrolling interest | 167 | 62 | 19 | 16 | ||||
| Other undisclosed net income (loss) attributable to parent | (248) | (19) | 70 | |||||
| Net income attributable to parent: | 5,755 | 5,947 | 5,558 | 1,700 | 351 | 193 | ||
| Other undisclosed net loss available to common stockholders, basic | (73) | (326) | ||||||
| Net income available to common stockholders, diluted: | 5,682 | 5,621 | 5,558 | 1,700 | 351 | 193 | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 5/31/2017 Q2 | 2/28/2017 Q1 | 11/30/2016 Q4 | 8/31/2016 Q3 | 5/31/2016 Q2 | 2/29/2016 Q1 | 11/30/2015 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 5,755 | 6,195 | 5,391 | 1,638 | 351 | 107 | ||
| Other comprehensive income | 53 | 146 | 196 | |||||
| Other undisclosed comprehensive loss | (1,456) | |||||||
| Comprehensive income: | 5,808 | 4,739 | 5,391 | 1,638 | 496 | 302 | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 74 | (271) | 18 | 73 | 9 | (9) | ||
| Other undisclosed comprehensive income, net of tax, attributable to parent | ||||||||
| Comprehensive income, net of tax, attributable to parent: | 5,882 | 4,468 | 5,410 | 1,711 | 506 | 293 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.